Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

36.54USD
19 Oct 2018
Change (% chg)

$-0.99 (-2.64%)
Prev Close
$37.53
Open
$37.41
Day's High
$37.70
Day's Low
$36.35
Volume
2,445,770
Avg. Vol
1,614,176
52-wk High
$39.43
52-wk Low
$24.54

Mahoney, Michael 

Mr. Michael F. Mahoney is Chairman of the Board, President, Chief Executive Officer of the Company. He joined the Company as our President in October 2011, and became our President and Chief Executive Officer and a director in November 2012. Mr. Mahoney became our Chairman of the Board in May 2016. Prior to joining the Company, he was Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson from January 2011 to September 2011, overseeing 50,000 employees and seven franchises. Prior to assuming this position, Mr. Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange, a provider of supply chain solutions and services that brings together hospitals, manufacturers, distributors and group purchasing organizations. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business. Mr. Mahoney earned a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University.

Basic Compensation

Total Annual Compensation, USD 3,069,450
Restricted Stock Award, USD 7,225,610
Long-Term Incentive Plans, USD --
All Other, USD 2,789,390
Fiscal Year Total, USD 13,084,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Mahoney

13,084,500

Daniel Brennan

3,632,770

Kevin Ballinger

2,808,570

Joseph Fitzgerald

5,839,000

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2017